Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Qiang Ren, Yiqing Fan, Lixin Yang, Mayu Shan, Wei Shi & Hai Qian. (2023) An updated patent review of GPR40/ FFAR1 modulators (2020 – present). Expert Opinion on Therapeutic Patents 33:9, pages 565-577.
Read now
Read now
Wanqiu Huang, Luyong Zhang & Zheng Li. (2022) Advances in computer-aided drug design for type 2 diabetes. Expert Opinion on Drug Discovery 17:5, pages 461-472.
Read now
Read now
Yuqing Zhao, Lijun Xie, Ning Ou, Jie Wu, Hongwen Zhang, Sufeng Zhou, Yun Liu, Juan Chen, Lu Wang, Libin Wang, Jingjing Wang & Feng Shao. (2021) Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects. Xenobiotica 51:3, pages 297-306.
Read now
Read now
Articles from other publishers (37)
Dapinder Pal Singh Loona, Bhanuranjan Das, Ramandeep Kaur, Rajnish Kumar & Ashok Kumar Yadav. (2023) Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets
for the Management of Diabetes Mellitus. Current Medicinal Chemistry 30:30, pages 3404-3440.
Crossref
Crossref
Jingqian Su, Yingsheng Luo, Shan Hu, Lu Tang & Songying Ouyang. (2023) Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents. International Journal of Molecular Sciences 24:17, pages 13381.
Crossref
Crossref
Cristina Floriana Pană, Dorin Popescu & Virginia Maria Rădulescu. (2023) Patent Review of Lower Limb Rehabilitation Robotic Systems by Sensors and Actuation Systems Used. Sensors 23:13, pages 6237.
Crossref
Crossref
Darya A. Pon’kina, Sergey O. Kuranov, Mariya K. Marenina, Yulia V. Meshkova, Nataliya A. Zhukova, Mikhail V. Khvostov, Olga A. Luzina, Tatiana G. Tolstikova & Nariman F. Salakhutdinov. (2023) Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies. Pharmaceutics 15:6, pages 1670.
Crossref
Crossref
Cheng Chen, Shi-Meng Guo, Yuanjun Sun, He Li, Nan Hu, Kun Yao, Huxin Ni, Zhikan Xia, Bin Xu, Xin Xie & Ya-Qiu Long. (2023) Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid. European Journal of Medicinal Chemistry 251, pages 115267.
Crossref
Crossref
Doo Yeong Kim & Jong-Hyuk Sung. (2023) The effects of GPR40 agonists on hair growth are mediated by ANGPTL4. Biomedicine & Pharmacotherapy 161, pages 114509.
Crossref
Crossref
Igor Solovyev, Dmitry Dar'in & Mikhail Krasavin. (2023) Diazo chemistry in the access to novel fatty acids linked to spiro-fused oxetane-pyrazolone scaffold. Mendeleev Communications 33:1, pages 21-23.
Crossref
Crossref
Bin Wang, Zongyu Cai, Huixin Yao, Shixuan Jiao, Siliang Chen, Zhongcheng Yang, Wanqiu Huang, Qiang Ren, Zhijun Cao, Ya Chen, Luyong Zhang & Zheng Li. (2023) Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes. European Journal of Medicinal Chemistry 245, pages 114883.
Crossref
Crossref
Zheng Li, Lianru Chen & Luyong Zhang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
357
375
.
Michael Lückmann, Aslihan Shenol, Tinne A. D. NissenJacob E. Petersen, David Kouvchinov, Thue W. Schwartz & Thomas M. Frimurer. (2022) Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action. ACS Medicinal Chemistry Letters 13:12, pages 1839-1847.
Crossref
Crossref
Jagat Pal Yadav, Dinesh Kumar Patel, Prateek Pathak & Maria Grishina. (2022) Role of G-protein coupled receptor (GPCRs)/(GPR-120) as an agonists in diabetic wound healing. Obesity Medicine 36, pages 100466.
Crossref
Crossref
Doreen Thor. (2022) G protein-coupled receptors as regulators of pancreatic islet functionality. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:5, pages 119235.
Crossref
Crossref
Virendra Nath, Rakesh Kumar Paul, Neeraj Kumar & Vipin Kumar. (2022) Identification of behenic acid as medicinal food for the diabetes mellitus: structure-based computational approach and molecular dynamics simulation studies. Journal of Molecular Modeling 28:3.
Crossref
Crossref
Bin Wang, Zongyu Cai, Siliang Chen, Ya Chen, Shixuan Jiao, Qiang Ren, Xuekun Wang, Xinqian Geng, Zheng Li & Guangji Wang. (2022) Design, synthesis, and biological evaluation of novel FFA1 partial agonists bearing oxime ether scaffold**. ChemistrySelect 7:2.
Crossref
Crossref
Brian D. Hudson. 2022. Allosteric Modulation of G Protein-Coupled Receptors. Allosteric Modulation of G Protein-Coupled Receptors
97
116
.
Mateusz Mach, Katarzyna Bazydło-Guzenda, Paweł Buda, Mikołaj Matłoka, Radosław Dzida, Filip Stelmach, Kinga Gałązka, Małgorzata Wąsińska-Kałwa, Damian Smuga, Dagmara Hołowińska, Urszula Dawid, Lidia Gurba-Bryśkiewicz, Krzysztof Wiśniewski, Krzysztof Dubiel, Jerzy Pieczykolan & Maciej Wieczorek. (2021) Discovery and development of CPL207280 as new GPR40/FFA1 agonist. European Journal of Medicinal Chemistry 226, pages 113810.
Crossref
Crossref
Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chigurupati, Rajwinder Kaur, Saurabh Bhatia, Ahmed Al-Harrasi, Celia Vargas-De-La-Cruz & Simona Bungau. (2021) Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus. Inflammopharmacology 29:6, pages 1625-1639.
Crossref
Crossref
Jian-Hong Lin, Huan-Hsin Chang, Wen-Sen Lee, Pei-Ching Ting, Yu-Po Luo & Kun-Ta Yang. (2021) Palmitic Acid Methyl Ester Enhances Adipogenic Differentiation in Rat Adipose Tissue-Derived Mesenchymal Stem Cells through a G Protein-Coupled Receptor-Mediated Pathway. Stem Cells International 2021, pages 1-14.
Crossref
Crossref
Katarzyna Bazydlo-Guzenda, Pawel Buda, Mateusz Mach, Jerzy Pieczykolan, Izabela Kozlowska, Michal Janiszewski, Ewa Drzazga, Jakub Dominowski, Hubert Ziolkowski, Maciej Wieczorek & Shayne Cox Gad. (2021) Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey. PLOS ONE 16:9, pages e0257477.
Crossref
Crossref
Wei Ge, Benhui Yang, Lianru Chen, Zongtao Zhou & Yao Jin. (2021) Discovery of Novel G‐Protein‐Coupled Receptor 40 Agonist with Phenylacetic Acid Scaffold for the Treatment of Type 2 Diabetes. ChemistrySelect 6:29, pages 7372-7375.
Crossref
Crossref
Jaroslawna Meister, Lei Wang, Sai P. Pydi & Jürgen Wess. (2021) Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications. Journal of Neurochemistry 158:3, pages 603-620.
Crossref
Crossref
O. Yu. Kytikova, T. P. Novgorodtseva, Yu. K. Denisenko, M. V. Antonyuk & T. A. Gvozdenko. (2021) Medium and long chain free fatty acid receptors in the pathophysiology of respiratory diseases. Bulletin Physiology and Pathology of Respiration:80, pages 115-128.
Crossref
Crossref
Xu Chen, Zhidong Chen, Daiyun Xu, Yonghui Lyu, Yongxiao Li, Shengbin Li, Junqing Wang & Zhe Wang. (2021) De novo Design of G Protein-Coupled Receptor 40 Peptide Agonists for Type 2 Diabetes Mellitus Based on Artificial Intelligence and Site-Directed Mutagenesis. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Paolo Governa, Maria Cristina Caroleo, Gabriele Carullo, Francesca Aiello, Erika Cione & Fabrizio Manetti. (2021) FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicity. Bioorganic & Medicinal Chemistry Letters 41, pages 127969.
Crossref
Crossref
Gabriele Carullo, Sarah Mazzotta, Margarita Vega-Holm, Fernando Iglesias-Guerra, José Manuel Vega-Pérez, Francesca Aiello & Antonella Brizzi. (2021) GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery. Journal of Medicinal Chemistry 64:8, pages 4312-4332.
Crossref
Crossref
Ryokichi Koyama, Mitsugi Ookawara, Masanori Watanabe & Yusuke Moritoh. (2021) Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats. Molecular Pharmacology 99:4, pages 286-293.
Crossref
Crossref
Luiz F. Barella, Shanu Jain, Takefumi Kimura & Sai P. Pydi. (2021) Metabolic roles of G protein‐coupled receptor signaling in obesity and type 2 diabetes. The FEBS Journal 288:8, pages 2622-2644.
Crossref
Crossref
Alexey Lukin, Anna Bakholdina, Nikolay Zhurilo, Oleksandra Onopchenko, Elena Zhuravel, Sergey Zozulya, Maxim Gureev, Alexander Safrygin & Mikhail Krasavin. (2020) Exploration of the nitrogen heterocyclic periphery around the core of the advanced FFA1 agonist fasiglifam (TAK‐875). Archiv der Pharmazie 354:4.
Crossref
Crossref
Lata Rani, Ajmer Singh Grewal, Neelam Sharma & Sukhbir Singh. (2021) Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus. Mini-Reviews in Medicinal Chemistry 21:4, pages 426-470.
Crossref
Crossref
Manuel Grundmann, Eckhard Bender, Jens Schamberger & Frank Eitner. (2021) Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. International Journal of Molecular Sciences 22:4, pages 1763.
Crossref
Crossref
Lei WangLu ZhuJaroslawna MeisterDerek B.J. BoneSai P. PydiMario RossiJürgen Wess. (2021) Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs. Annual Review of Pharmacology and Toxicology 61:1, pages 421-440.
Crossref
Crossref
So-Eun Son, Nam-Jung Kim & Dong-Soon Im. (2021) Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science. Biomolecules & Therapeutics 29:1, pages 22-30.
Crossref
Crossref
Zhongyang Lu, Yanchun Li, Wing-Kin Syn, Ai-Jun Li, W. Sue Ritter, Stephen A. Wank, Maria F. Lopes-Virella & Yan Huang. (2021) GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice. American Journal of Physiology-Endocrinology and Metabolism 320:1, pages E30-E42.
Crossref
Crossref
Lijun Hu, Zongtao Zhou, Liming Deng, Qiang Ren, Zongyu Cai, Bin Wang, Zheng Li & Guangji Wang. (2020) HWL-088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis. Journal of Pharmacy and Pharmacology 72:11, pages 1564-1573.
Crossref
Crossref
Hideki Furukawa, Yasufumi Miyamoto, Yasuhiro Hirata, Koji Watanabe, Yuko Hitomi, Yayoi Yoshitomi, Jumpei Aida, Naoyoshi Noguchi, Nobuyuki Takakura, Kazuaki Takami, Seiji Miwatashi, Yoshihiko Hirozane, Teruki Hamada, Ryo Ito, Mitsugi Ookawara, Yusuke Moritoh, Masanori Watanabe & Tsuyoshi Maekawa. (2020)
Design and Identification of a GPR40 Full Agonist (
SCO-267
) Possessing a 2-Carbamoylphenyl Piperidine Moiety
. Journal of Medicinal Chemistry 63:18, pages 10352-10379.
Crossref
Crossref
Hongguang Ma, Boshi Huang & Yan Zhang. (2020) Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors. Drug Discovery Today 25:9, pages 1682-1692.
Crossref
Crossref
Sergey O. Kuranov, Olga A. Luzina, Oleksandra Onopchenko, Iryna Pishel, Sergey Zozulya, Maxim Gureev, Nariman F. Salakhutdinov & Mikhail Krasavin. (2020) Exploring bulky natural and natural-like periphery in the design of p-(benzyloxy)phenylpropionic acid agonists of free fatty acid receptor 1 (GPR40). Bioorganic Chemistry 99, pages 103830.
Crossref
Crossref